9.55 USD
+0.17 (+1.81%)
At close: Jan 30, 2026
9.55 USD
0 (0%)
After Hours: 1/30/2026, 8:00:02 PM
We assign a fundamental rating of 3 out of 10 to IMTX. IMTX was compared to 525 industry peers in the Biotechnology industry. The financial health of IMTX is average, but there are quite some concerns on its profitability. IMTX is valied quite expensively at the moment, while it does show a decent growth rate.
1. Profitability
1.1 Basic Checks
- IMTX had negative earnings in the past year.
- IMTX had a negative operating cash flow in the past year.
- The reported net income has been mixed in the past 5 years: IMTX reported negative net income in multiple years.
- In multiple years IMTX reported negative operating cash flow during the last 5 years.
1.2 Ratios
- IMTX's Return On Assets of -22.35% is fine compared to the rest of the industry. IMTX outperforms 73.71% of its industry peers.
- Looking at the Return On Equity, with a value of -27.81%, IMTX is in the better half of the industry, outperforming 78.29% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -22.35% | ||
| ROE | -27.81% | ||
| ROIC | N/A |
ROA(3y)-2.39%
ROA(5y)-28.72%
ROE(3y)-7.75%
ROE(5y)-130.43%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- IMTX does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | N/A |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
2. Health
2.1 Basic Checks
- IMTX does not have a ROIC to compare to the WACC, probably because it is not profitable.
- IMTX has more shares outstanding than it did 1 year ago.
- The number of shares outstanding for IMTX has been increased compared to 5 years ago.
- Compared to 1 year ago, IMTX has an improved debt to assets ratio.
2.2 Solvency
- IMTX has an Altman-Z score of 3.86. This indicates that IMTX is financially healthy and has little risk of bankruptcy at the moment.
- IMTX's Altman-Z score of 3.86 is fine compared to the rest of the industry. IMTX outperforms 71.24% of its industry peers.
- IMTX has a Debt/Equity ratio of 0.03. This is a healthy value indicating a solid balance between debt and equity.
- IMTX has a Debt to Equity ratio (0.03) which is in line with its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.03 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 3.86 |
ROIC/WACCN/A
WACC7.41%
2.3 Liquidity
- IMTX has a Current Ratio of 7.36. This indicates that IMTX is financially healthy and has no problem in meeting its short term obligations.
- With a decent Current ratio value of 7.36, IMTX is doing good in the industry, outperforming 72.00% of the companies in the same industry.
- IMTX has a Quick Ratio of 7.36. This indicates that IMTX is financially healthy and has no problem in meeting its short term obligations.
- IMTX's Quick ratio of 7.36 is fine compared to the rest of the industry. IMTX outperforms 72.19% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 7.36 | ||
| Quick Ratio | 7.36 |
3. Growth
3.1 Past
- The earnings per share for IMTX have decreased strongly by -55.17% in the last year.
- IMTX shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -26.62%.
- The Revenue has been growing by 53.31% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-55.17%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-425%
Revenue 1Y (TTM)-26.62%
Revenue growth 3Y64.83%
Revenue growth 5Y53.31%
Sales Q2Q%-89.74%
3.2 Future
- The Earnings Per Share is expected to decrease by -52.12% on average over the next years. This is quite bad
- The Revenue is expected to grow by 14.40% on average over the next years. This is quite good.
EPS Next Y-1210.1%
EPS Next 2Y-254.44%
EPS Next 3Y-130.99%
EPS Next 5Y-52.12%
Revenue Next Year-66.71%
Revenue Next 2Y-36.96%
Revenue Next 3Y-21.06%
Revenue Next 5Y14.4%
3.3 Evolution
- Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
4. Valuation
4.1 Price/Earnings Ratio
- IMTX reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
- Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for IMTX. No positive earnings are expected for the next year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
- IMTX's earnings are expected to decrease with -130.99% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-254.44%
EPS Next 3Y-130.99%
5. Dividend
5.1 Amount
- IMTX does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
IMMATICS NV / IMTX FAQ
What is the fundamental rating for IMTX stock?
ChartMill assigns a fundamental rating of 3 / 10 to IMTX.
Can you provide the valuation status for IMMATICS NV?
ChartMill assigns a valuation rating of 0 / 10 to IMMATICS NV (IMTX). This can be considered as Overvalued.
What is the profitability of IMTX stock?
IMMATICS NV (IMTX) has a profitability rating of 2 / 10.
Can you provide the financial health for IMTX stock?
The financial health rating of IMMATICS NV (IMTX) is 5 / 10.
What is the earnings growth outlook for IMMATICS NV?
The Earnings per Share (EPS) of IMMATICS NV (IMTX) is expected to decline by -1210.1% in the next year.